166 related articles for article (PubMed ID: 10080567)
1. Association between brain functional failure and dementia severity in Alzheimer's disease: resting versus stimulation PET study.
Pietrini P; Furey ML; Alexander GE; Mentis MJ; Dani A; Guazzelli M; Rapoport SI; Schapiro MB
Am J Psychiatry; 1999 Mar; 156(3):470-3. PubMed ID: 10080567
[TBL] [Abstract][Full Text] [Related]
2. Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Pietrini P; Dani A; Furey ML; Alexander GE; Freo U; Grady CL; Mentis MJ; Mangot D; Simon EW; Horwitz B; Haxby JV; Schapiro MB
Am J Psychiatry; 1997 Aug; 154(8):1063-9. PubMed ID: 9247390
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolic response to passive audiovisual stimulation in patients with Alzheimer's disease and healthy volunteers assessed by PET.
Pietrini P; Alexander GE; Furey ML; Dani A; Mentis MJ; Horwitz B; Guazzelli M; Shapiro MB; Rapoport SI
J Nucl Med; 2000 Apr; 41(4):575-83. PubMed ID: 10768555
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
5. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
Alexander GE; Furey ML; Grady CL; Pietrini P; Brady DR; Mentis MJ; Schapiro MB
Am J Psychiatry; 1997 Feb; 154(2):165-72. PubMed ID: 9016263
[TBL] [Abstract][Full Text] [Related]
6. Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Pietrini P; Furey ML; Graff-Radford N; Freo U; Alexander GE; Grady CL; Dani A; Mentis MJ; Schapiro MB
Am J Psychiatry; 1996 Oct; 153(10):1261-8. PubMed ID: 8831432
[TBL] [Abstract][Full Text] [Related]
7. Increasing required neural response to expose abnormal brain function in mild versus moderate or severe Alzheimer's disease: PET study using parametric visual stimulation.
Mentis MJ; Alexander GE; Krasuski J; Pietrini P; Furey ML; Schapiro MB; Rapoport SI
Am J Psychiatry; 1998 Jun; 155(6):785-94. PubMed ID: 9619151
[TBL] [Abstract][Full Text] [Related]
8. Association between cognitive performance and cortical glucose metabolism in patients with mild Alzheimer's disease.
Bokde AL; Teipel SJ; Drzezga A; Thissen J; Bartenstein P; Dong W; Leinsinger G; Born C; Schwaiger M; Moeller HJ; Hampel H
Dement Geriatr Cogn Disord; 2005; 20(6):352-7. PubMed ID: 16192725
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Vander Borght T; Minoshima S; Giordani B; Foster NL; Frey KA; Berent S; Albin RL; Koeppe RA; Kuhl DE
J Nucl Med; 1997 May; 38(5):797-802. PubMed ID: 9170449
[TBL] [Abstract][Full Text] [Related]
10. Combined study of cerebral glucose metabolism and [11C]methionine accumulation in probable Alzheimer's disease using positron emission tomography.
Salmon E; Gregoire MC; Delfiore G; Lemaire C; Degueldre C; Franck G; Comar D
J Cereb Blood Flow Metab; 1996 May; 16(3):399-408. PubMed ID: 8621744
[TBL] [Abstract][Full Text] [Related]
11. Delusional thoughts and regional frontal/temporal cortex metabolism in Alzheimer's disease.
Sultzer DL; Brown CV; Mandelkern MA; Mahler ME; Mendez MF; Chen ST; Cummings JL
Am J Psychiatry; 2003 Feb; 160(2):341-9. PubMed ID: 12562582
[TBL] [Abstract][Full Text] [Related]
12. Cortical abnormalities in Alzheimer's disease.
Foster NL; Chase TN; Mansi L; Brooks R; Fedio P; Patronas NJ; Di Chiro G
Ann Neurol; 1984 Dec; 16(6):649-54. PubMed ID: 6335378
[TBL] [Abstract][Full Text] [Related]
13. Frontal lobe tasks do not reflect frontal lobe function in patients with probable Alzheimer's disease.
Kessler J; Mielke R; Grond M; Herholz K; Heiss WD
Int J Neurosci; 2000; 104(1-4):1-15. PubMed ID: 11011970
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography in Alzheimer's disease.
Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI
Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046
[TBL] [Abstract][Full Text] [Related]
16. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
[TBL] [Abstract][Full Text] [Related]
17. Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease.
Hirono N; Mori E; Ishii K; Kitagaki H; Sasaki M; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Yamashita H
J Neuropsychiatry Clin Neurosci; 1998; 10(4):433-9. PubMed ID: 9813789
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
McGeer PL; Kamo H; Harrop R; Li DK; Tuokko H; McGeer EG; Adam MJ; Ammann W; Beattie BL; Calne DB
CMAJ; 1986 Mar; 134(6):597-607. PubMed ID: 3512063
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between three neuropsychological tests and cerebral glucose metabolism in Alzheimer's disease].
Zhang XQ; Min BQ; Ma YC; Yang PJ; Li DP
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):100-2. PubMed ID: 12812674
[TBL] [Abstract][Full Text] [Related]
20. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE
J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]